Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1130 result(s) found, displaying 901 to 925

  • AusPAR: Eribulin mesilate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Eribulin mesilate

  • AusPAR: Everolimus

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Everolimus

  • AusPAR: Exenatide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Exenatide

  • AusPAR: Sitagliptin / Metformin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Sitagliptin / Metformin

  • AusPAR: Ezetimibe

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ezetimibe

  • AusPAR: Olmesartan medoxomil

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Olmesartan medoxomil

  • AusPAR: Somatropin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Somatropin

  • AusPAR: Rifaximin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Rifaximin

  • AusPAR: Cyclizine lactate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Cyclizine lactate

  • AusPAR: Ibuprofen

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ibuprofen

  • AusPAR: Erlotinib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Erlotinib

  • AusPAR: Strontium ranelate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Strontium ranelate

  • AusPAR: Bortezomib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Bortezomib

  • AusPAR: Trastuzumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Trastuzumab

  • AusPAR: Vemurafenib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Vemurafenib

  • AusPAR: Infliximab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Infliximab

  • AusPAR: Vernakalant

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Vernakalant